Monte Rosa Therapeutics Debt-to-Assets Ratio Growth & History (GLUE)

Monte Rosa Therapeutics's debt-to-assets ratio was 0.09 for fiscal 2025.

View full Monte Rosa Therapeutics company overview

Monte Rosa Therapeutics annual debt-to-assets ratio history

Monte Rosa Therapeutics annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.09−0.01−10.28%
20242024-12-310.10−0.05−35.76%
20232023-12-310.150.01+10.41%
20222022-12-310.140.14
20212021-12-310.00

Monte Rosa Therapeutics debt-to-assets ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Monte Rosa Therapeutics's debt-to-assets ratio increased from 0.00 to 0.09, a change of 0.09. The latest reported quarter, Q2 2026, shows 0.05.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Monte Rosa Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about GLUE yet. Start the conversation.

Write the first post